When developing generic products, reviewing the Drug Master File (DMF) is a critical step. Finished product manufacturers are expected to thoroughly assess the DMF to ensure compliance, quality, and smooth approval process.
Here’s a simple, effective way to approach DMF review:
1. Administrative Details
- DMF holder’s info and type (API, packaging, etc.)
- Reference letters/commitments to authorities
2. Manufacturing Process & Controls
- Stepwise API synthesis or excipient manufacturing
- In-process controls and critical parameters
Process validation history
3. Quality Control & Specifications
- Purity, assay, impurities, and analytical methods
- Stability data, retest, and shelf-life
- Cross-check against finished product formulation
4. Regulatory Compliance Evidence
- GMP certificates, CEPs, inspection reports
- Previous approvals or correspondence
- CDSCO-specific documents for India filings
5. Critical Risk Areas
- Impurities, residual solvents, heavy metals
- Microbial limits and endotoxin concerns
- Packaging compatibility if mentioned in DMF
Pro Tip: Use a structured checklist to review DMFs. Align every section with your regulatory filing requirements to prevent gaps and authority queries.
Team Check:
- Regulatory Affairs – Are all DMFs fully aligned with finished product specs for India, US, EU, and SFDA?
- Quality Assurance – Do we have a checklist to catch risks early?
- R&D – Any API-specific challenges to investigate before formulation?
DMF review isn’t just compliance—it’s strategic. Do it right, and you ensure smoother approvals, stronger products, and audit-ready files.
Read also: Understanding CEP, DMF, CADIFA and ASMF
Resource Person: Kaunain Kareem Khan